Does altered Ki67 expression in recurrent membranous basal cell adenoma point toward the need for reclassification?

The pathogenesis of membranous BCA recurrence remains unclear, with only a few cases reported. The current study focuses on a case that exhibits a high Ki-67 proliferative index, which raises questions about its impact on the prognosis and treatment plan. We have conducted a literature review to gai...

Full description

Saved in:
Bibliographic Details
Main Authors: Dhinakaran Paranchodi, Ashok Vikey, Jaya Joshi, Ramya Selvam, Neha Choudhary
Format: Article
Language:English
Published: Elsevier 2024-09-01
Series:Oral Oncology Reports
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2772906024004771
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841553684764295168
author Dhinakaran Paranchodi
Ashok Vikey
Jaya Joshi
Ramya Selvam
Neha Choudhary
author_facet Dhinakaran Paranchodi
Ashok Vikey
Jaya Joshi
Ramya Selvam
Neha Choudhary
author_sort Dhinakaran Paranchodi
collection DOAJ
description The pathogenesis of membranous BCA recurrence remains unclear, with only a few cases reported. The current study focuses on a case that exhibits a high Ki-67 proliferative index, which raises questions about its impact on the prognosis and treatment plan. We have conducted a literature review to gain insight into the altered ki67 expression pattern in membranous BCA. We have also proposed a hypothesis that suggests recurrent membranous BCA cases with Ki67 levels between 5 % and 10 % signify an intermediate grade and warrant reclassification. More research is needed to confirm this hypothesis and understand the prognosis for this variant.
format Article
id doaj-art-9f664ca8595348b5a935e16cfc0dcd30
institution Kabale University
issn 2772-9060
language English
publishDate 2024-09-01
publisher Elsevier
record_format Article
series Oral Oncology Reports
spelling doaj-art-9f664ca8595348b5a935e16cfc0dcd302025-01-09T06:16:59ZengElsevierOral Oncology Reports2772-90602024-09-0111100631Does altered Ki67 expression in recurrent membranous basal cell adenoma point toward the need for reclassification?Dhinakaran Paranchodi0Ashok Vikey1Jaya Joshi2Ramya Selvam3Neha Choudhary4Dept of Oral & Maxillofacial Pathology & Oral Microbiology, Government College of Dentistry, Indore, IndiaDept of Oral & Maxillofacial Pathology & Oral Microbiology, Government College of Dentistry, Indore, IndiaDept of Oral & Maxillofacial Pathology & Oral Microbiology, Government College of Dentistry, Indore, IndiaCorresponding author.; Oral and Maxillofacial Pathologist and Oral Microbiologist, Dept of Dental Surgery, Lala Lajpat Rai Memorial Medical College, Meerut, IndiaDept of Oral & Maxillofacial Pathology & Oral Microbiology, Government College of Dentistry, Indore, IndiaThe pathogenesis of membranous BCA recurrence remains unclear, with only a few cases reported. The current study focuses on a case that exhibits a high Ki-67 proliferative index, which raises questions about its impact on the prognosis and treatment plan. We have conducted a literature review to gain insight into the altered ki67 expression pattern in membranous BCA. We have also proposed a hypothesis that suggests recurrent membranous BCA cases with Ki67 levels between 5 % and 10 % signify an intermediate grade and warrant reclassification. More research is needed to confirm this hypothesis and understand the prognosis for this variant.http://www.sciencedirect.com/science/article/pii/S2772906024004771Basal cell adenomaMembranous variantKi67and β -catenin
spellingShingle Dhinakaran Paranchodi
Ashok Vikey
Jaya Joshi
Ramya Selvam
Neha Choudhary
Does altered Ki67 expression in recurrent membranous basal cell adenoma point toward the need for reclassification?
Oral Oncology Reports
Basal cell adenoma
Membranous variant
Ki67
and β -catenin
title Does altered Ki67 expression in recurrent membranous basal cell adenoma point toward the need for reclassification?
title_full Does altered Ki67 expression in recurrent membranous basal cell adenoma point toward the need for reclassification?
title_fullStr Does altered Ki67 expression in recurrent membranous basal cell adenoma point toward the need for reclassification?
title_full_unstemmed Does altered Ki67 expression in recurrent membranous basal cell adenoma point toward the need for reclassification?
title_short Does altered Ki67 expression in recurrent membranous basal cell adenoma point toward the need for reclassification?
title_sort does altered ki67 expression in recurrent membranous basal cell adenoma point toward the need for reclassification
topic Basal cell adenoma
Membranous variant
Ki67
and β -catenin
url http://www.sciencedirect.com/science/article/pii/S2772906024004771
work_keys_str_mv AT dhinakaranparanchodi doesalteredki67expressioninrecurrentmembranousbasalcelladenomapointtowardtheneedforreclassification
AT ashokvikey doesalteredki67expressioninrecurrentmembranousbasalcelladenomapointtowardtheneedforreclassification
AT jayajoshi doesalteredki67expressioninrecurrentmembranousbasalcelladenomapointtowardtheneedforreclassification
AT ramyaselvam doesalteredki67expressioninrecurrentmembranousbasalcelladenomapointtowardtheneedforreclassification
AT nehachoudhary doesalteredki67expressioninrecurrentmembranousbasalcelladenomapointtowardtheneedforreclassification